the project is pending for the construction license approval process of the project, which delays due to change in policy on procedure and the license approval process of the licensing agency, which is
change in policy on procedure and the license approval process of the licensing agency, which is the Department of Energy, Ministry of Energy, the Philippines. It is still in the process of reviewing
agreement have been fulfilled. Currently, the status of the project is pending for the construction license approval process of the project, which delays due to change in policy on procedure and the license
earnings translation. US$ 155M lower EBITDA in LTM3Q19 and US$ 22M in 3Q19 due to unplanned shutdowns, catalysts change planned shurdown in EOEG assets in USA and one line conversion from PTA to IPA in USA
intervention of the government to determine the CPO pricing policy, economic change, climate change, and demand and supply. In the past 2 years, CPO’s world and Thai’s market had been highly volatilized. The
under trademark “Wuttisak Clinic” the Company has change the business strategy for appropriate with the business environment by closed 7 departments which have accumulate loss in July 2019 and decreased
its subsidiaries as details below: (Unit: Baht millions) For the period of three months Consolidated financial statement ended 30th June Apr 2019 - June 2019 Apr 2018 - June 2018 Change % Change Revenue
distribution 234 351 118 50.4 749 957 208 27.8 Others 23 18 (5) (21.8) 38 43 5 14.3 Total 3,627 3,862 235 6.5 10,582 10,976 394 3.7 For the 3-month period ended Change For the 9-month period ended Change
subsidiaries as details below: (Unit: Baht millions) For the year ended 31st March Consolidated financial statement Apr 2019 - Mar 2020 Apr 2018 - Mar 2019 Change % Change Revenue from sales & service 2,756.44